Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-Escalated IGRT With MRI-Based Target Definition for Prostate Cancer
NCT07900555Phase 2Completed
- Sponsor
- Haukeland University Hospital
- Start
- Feb 2014
- Primary completion
- Oct 2025
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in prostate cancer (PCa), sponsored by Haukeland University Hospital. Primary endpoint: Clinical and Biochemical Disease Control at 10 years. Started Feb 2014; status: completed.
02
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT07900555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07900555.